Investments, Funding & Disinvestment

Through this acquisition, Mirum gains worldwide rights to brelovitug, a monoclonal antibody that has advanced to Phase III clinical development.

The award acknowledges Sanofi’s consistent efforts in creating sustainable employment opportunities for Saudi nationals while simultaneously building robust leadership capabilities across its regional operations.

The conference attracted regulators, manufacturers, healthcare providers, and industry stakeholders who gathered to examine priorities shaping modern healthcare delivery.

The partnership between these companies stems from a late 2024 licensing agreement in which Corxel obtained worldwide rights to CX11, excluding China, from Vincentage.

The local production of dydrogesterone represents not only an important milestone for Mubadala Bio and Bioventure Healthcare but also a timely contribution to supporting women’s health throughout the country.

The grant will enable Qure.ai to develop a comprehensive open-source multi-modal database designed to accelerate future prevention and identification innovations.

BMS will pay up to USD850 million, structured as USD50 million in upfront and near-term payments combined with USD800 million in regulatory, development, and milestone-based payouts.

The acquisition adds two key products to BioStem’s portfolio: Neox and Clarix, both cryopreserved amniotic membrane allografts.

Medical professionals will now conduct tests for liver function, kidney function, cardiac markers, and tumour markers directly at the facility.

Pfizer will assume complete responsibility for developing and bringing to market any vaccine products that utilize Matrix-M technology.